Aravive Biologics, a biopharmaceutical company that recently moved its headquarters to Houston, has named a new president and CEO.
Dr. Stephen Eck took over the roles from founding President and CEO Dr. Ray Tabibiazar, who remains chairman of the company’s board of directors.
“Stephen has an impressive track record of oncology drug and biomarker development at prominent pharmaceutical companies, as well as a close relationship to Houston’s M.D. Anderson Cancer Center as a member of the advisory…
Biotech company names new CEO after relocating to Houston syndicated post